Therapeutic Effect of Losartan, an Angiotensin II Type 1 Receptor Antagonist, on CCl4-Induced Skeletal Muscle Injury

Author： Hwang Ok-Kyung   Park Jin-Kyu   Lee Eun-Joo   Lee Eun-Mi   Kim Ah-Young   Jeong Kyu-Shik  

Publisher： MDPI

E-ISSN： 1422-0067|17|2|227-227

ISSN： 1422-0067

Source： International Journal of Molecular Sciences, Vol.17, Iss.2, 2016-02, pp. : 227-227

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

TGF-β1 is known to inhibit muscle regeneration after muscle injury. However, it is unknown if high systemic levels of TGF-β can affect the muscle regeneration process. In the present study, we demonstrated the effect of a CCl4 intra-peritoneal injection and losartan (an angiotensin II type 1 receptor antagonist) on skeletal muscle (gastrocnemius muscle) injury and regeneration. Male C57BL/6 mice were grouped randomly as follows: control (n = 7), CCl4-treatment group (n = 7), and CCl4 + losartan treatment group (n = 7). After CCl4 treatment for a 16-week period, the animals were sacrificed and analyzed. The expression of dystrophin significantly decreased in the muscle tissues of the control group, as compared with that of the CCl4 + losartan group (p < 0.01). p(phospho)-Smad2/3 expression significantly increased in the muscles of the control group compared to that in the CCl4 + losartan group (p < 0.01). The expressions of Pax7, MyoD, and myogenin increased in skeletal muscles of the CCl4 + losartan group compared to the corresponding levels in the control group (p < 0.01). We hypothesize that systemically elevated TGF-β1 as a result of CCl4-induced liver injury causes skeletal muscle injury, while losartan promotes muscle repair from injury via blockade of TGF-β1 signaling.

Related content

Anti-Fibrotic Effect of Losartan, an Angiotensin II Receptor Blocker, Is Mediated through Inhibition of ER Stress via Up-Regulation of SIRT1, Followed by Induction of HO-1 and Thioredoxin

By Kim Hyosang   Baek Chung Hee   Lee Raymond Bok   Chang Jai Won   Yang Won Seok   Lee Sang Koo  

International Journal of Molecular Sciences, Vol. 18, Iss. 2, 2017-01 ,pp. : 305-305 (1)

MDPI

Access to resources Recommend Favorite

12-Lipoxygenase Inhibition on Microalbuminuria in Type-1 and Type-2 Diabetes Is Associated with Changes of Glomerular Angiotensin II Type 1 Receptor Related to Insulin Resistance

By Xu Hong-Zhao   Cheng Yan-Li   Wang Wan-Ning   Wu Hao   Zhang Yuan-Yuan   Zang Chong-Sen   Xu Zhong-Gao  

International Journal of Molecular Sciences, Vol. 17, Iss. 5, 2016-05 ,pp. : 684-684 (1)

MDPI

Access to resources Recommend Favorite

Hyperhomocysteinemia Accelerates Collagen Accumulation in the Adventitia of Balloon-Injured Rat Carotid Arteries via Angiotensin II Type 1 Receptor

By Yao Dan   Sun Ning-Ling  

International Journal of Molecular Sciences, Vol. 15, Iss. 11, 2014-10 ,pp. : 19487-19498 (12)

MDPI

Access to resources Recommend Favorite

Interleukin-1 Receptor Antagonist Reduces Neonatal Lipopolysaccharide-Induced Long-Lasting Neurobehavioral Deficits and Dopaminergic Neuronal Injury in Adult Rats

By Pang Yi   Tien Lu-Tai   Zhu Hobart   Shen Juying   Wright Camilla F.   Jones Tembra K.   Mamoon Samir A.   Bhatt Abhay J.   Cai Zhengwei   Fan Lir-Wan  

International Journal of Molecular Sciences, Vol. 16, Iss. 4, 2015-04 ,pp. : 8635-8654 (20)

MDPI

Access to resources Recommend Favorite

SHSST Cyclodextrin Complex Prevents the Fibrosis Effect on CCl4-Induced Cirrhotic Cardiomyopathy in Rats through TGF-β Pathway Inhibition Effects

By Yang Cheng-Hsun   Ting Wei-Jen   Day Cecilia Hsuan   Ju Da-Tong   Yeh Yu-Lan   Chung Li-Chin   Tsai Fu-Jenn   Tsai Chang-Hai   Tsai Yuhsin   Huang Chih-Yang  

International Journal of Molecular Sciences, Vol. 15, Iss. 5, 2014-05 ,pp. : 8037-8048 (12)

MDPI

Access to resources Recommend Favorite